Top Markets
Coin of the day
Carmell Therapeutics Corporation Carmell Therapeutics Corporation

Carmell Therapeutics Corporation

CTCX
Kedudukan dalam Saham #36666
Carmell Therapeutics Corporation (CTCX) specializes in the creation of... Carmell Therapeutics Corporation (CTCX) specializes in the creation of plasma-based bioactive materials (PBMs) aimed at catalyzing tissue regeneration and repair following injury, illness, or the effects of aging. Their flagship product, CT-101, is a versatile accelerant with a dual focus. For orthopedic and dental applications, it's designed to enhance bone healing in cases such as tibia fractures, foot and ankle fusions, spinal fusions, and also serves as a dental bone graft substitute and bone void filler. Furthermore, CT-101 acts as a tissue healing accelerant, addressing conditions like androgenetic alopecia (pattern baldness) and persistent chronic wounds. Established in 2008, the company operates from its headquarters in Pittsburgh, Pennsylvania.
Harga Saham
$0.117
Disegerakkan terakhir: 2025-04-04
Modal Pasaran
$2.45M
Perubahan (1 hari)
-13.59%
Perubahan (1 tahun)
0.00%
Negara
US
Perdagangan Carmell Therapeutics Corporation (CTCX)

Kategori

EPS untuk Carmell Therapeutics Corporation (CTCX)
EPS setakat June 2026 TTM: $-4.71
Menurut laporan kewangan terkini dan harga saham Carmell Therapeutics Corporation, EPS semasa syarikat (TTM) adalah $-4.71. Pada akhir tahun 2023, syarikat mempunyai EPS sebanyak $-0.74 peningkatan berbanding EPS tahun 2022 iaitu $-0.50.
Sejarah EPS untuk Carmell Therapeutics Corporation dari 2021 hingga 2026
EPS pada akhir setiap tahun
Tahun EPS Ubah
2026 (TTM) $-4.71 842.00%
2024 $-0.50 -32.43%
2023 $-0.74 48.00%
2022 $-0.50 4,487.16%
2021 $-0.01 0.00%
EPS untuk syarikat atau pesaing yang serupa
Syarikat EPS Perbezaan EPS Negara
$17.32 -467.73%
US
$27.74 -688.96%
NL
- -
CH
- -
KR
$13.70 -390.87%
BE